Acutus Medical, Inc. (NASDAQ:AFIB) Sees Large Decrease in Short Interest

Acutus Medical, Inc. (NASDAQ:AFIB) was the recipient of a significant drop in short interest during the month of April. As of April 15th, there was short interest totalling 553,600 shares, a drop of 34.5% from the March 31st total of 845,200 shares. Based on an average daily volume of 2,250,000 shares, the days-to-cover ratio is currently 0.2 days. Approximately 2.9% of the shares of the stock are sold short.

Acutus Medical Stock Performance

NASDAQ AFIB opened at $0.17 on Friday. The stock’s fifty day moving average is $0.19 and its two-hundred day moving average is $0.25. The firm has a market capitalization of $4.95 million, a P/E ratio of -0.13 and a beta of 0.19. The company has a debt-to-equity ratio of 1.10, a quick ratio of 2.22 and a current ratio of 2.44. Acutus Medical has a fifty-two week low of $0.16 and a fifty-two week high of $1.09.

About Acutus Medical

Acutus Medical, Inc, an arrhythmia management company, designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs.